Avalo Therapeutics, Inc. (AVTX): 10-Q filed Nov 5, 2026

Form type

10-Q

Filing date

Nov 5, 2026

Accession number

0001534120-26-000057

Filer

Avalo Therapeutics, Inc. (CIK 1534120)